Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor
Vascular amyloid deposition is common in light-chain amyloidosis resulting in endothelial dysfunction. Human placental growth factor (PlGF), a member of the vascular endothelial growth factor family was found to be altered in diverse pathological conditions, e.g. endothelial dysfunction. This study...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2015
|
| In: |
Clinical research in cardiology
Year: 2015, Jahrgang: 104, Heft: 3, Pages: 250-257 |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-014-0779-y |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-014-0779-y Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007%2Fs00392-014-0779-y |
| Verfasserangaben: | Arnt V. Kristen, Johannes Rinn, Ute Hegenbart, David Lindenmaier, Corina Merkle, Christoph Röcken, Stefan Hardt, Evangelos Giannitsis, Hugo A. Katus |
| Zusammenfassung: | Vascular amyloid deposition is common in light-chain amyloidosis resulting in endothelial dysfunction. Human placental growth factor (PlGF), a member of the vascular endothelial growth factor family was found to be altered in diverse pathological conditions, e.g. endothelial dysfunction. This study evaluated the clinical role of PlGF in light-chain amyloidosis. |
|---|---|
| Beschreibung: | Published online: 21 October 2014 Gesehen am 29.05.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-014-0779-y |